Right ventricular failure predicts adverse outcome in patients with pulmonary hypertension (PH), and in subjects with left ventricular heart failure and is associated with interstitial fibrosis. This review manuscript discusses the cellular effectors and molecular mechanisms implicated in right ventricular fibrosis. The right ventricular interstitium contains vascular cells, fibroblasts, and immune cells, enmeshed in a collagen-based matrix. Right ventricular pressure overload in PH is associated with the expansion of the fibroblast population, myofibroblast activation, and secretion of extracellular matrix proteins. Mechanosensitive transduction of adrenergic signalling and stimulation of the renin-angiotensin-aldosterone cascade trigger the activation of right ventricular fibroblasts. Inflammatory cytokines and chemokines may contribute to expansion and activation of macrophages that may serve as a source of fibrogenic growth factors, such as transforming growth factor (TGF)-b. Endothelin-1, TGF-bs, and matricellular proteins co-operate to activate cardiac myofibroblasts, and promote synthesis of matrix proteins. In comparison with the left ventricle, the RV tolerates well volume overload and ischemia; whether the right ventricular interstitial cells and matrix are implicated in these favourable responses remains unknown. Expansion of fibroblasts and extracellular matrix protein deposition are prominent features of arrhythmogenic right ventricular cardiomyopathies and may be implicated in the pathogenesis of arrhythmic events. Prevailing conceptual paradigms on right ventricular remodelling are based on extrapolation of findings in models of left ventricular injury. Considering the unique embryologic, morphological, and physiologic properties of the RV and the clinical significance of right ventricular failure, there is a need further to dissect RV-specific mechanisms of fibrosis and interstitial remodelling.
Introduction
The right ventricle (RV) is no longer the 'forgotten chamber'. 1 Extensive clinical evidence supports the prognostic significance of right ventricular dysfunction in a wide range of cardiovascular conditions. In myocardial infarction 2 and in heart failure, 3,4 right ventricular dysfunction is associated with adverse outcome and may predict arrhythmic events, marking a high-risk group. 5 In patients with acute pulmonary embolism, persistent depression of right ventricular function is associated with recurrent thromboembolic events. 6 In patients with pulmonary hypertension (PH), right ventricular systolic dysfunction predicts adverse outcome irrespective of changes in pulmonary vascular resistance. 7 Although therapeutic interventions in PH are focused on the pulmonary vasculature, survival is significantly associated with improved right ventricular function, whereas changes in pulmonary vascular resistance have little relationship to outcome. 8 Considering the outstanding clinical significance of right ventricular failure, understanding of the cellular events and molecular signals responsible for adverse remodelling of the RV following injury should be a major priority in cardiovascular research. Over the past 20 years, cardiovascular investigators have appreciated the role of the cardiac interstitium in myocardial homeostasis and disease. Experimental studies have unravelled the complexity and phenotypic plasticity of cardiac interstitial cells and have challenged the traditional view of the cardiac extracellular matrix as a static structural scaffold. Following injury, the cardiac matrix is enriched through deposition of extracellular macromolecules that do not serve a structural role,
The interstitium in the healthy right ventricle
The adult mammalian heart is composed of cardiomyocytes, a rich microvascular network, and a highly cellular collagen-based interstitium ( Figure 1 ) that contains abundant fibroblast-like interstitial cells and smaller populations of macrophages, mast cells and dendritic cells. [12] [13] [14] [15] Interstitial cells play an important role in maintaining the cardiac extracellular matrix and may also transduce signals that regulate cardiomyocyte survival and function. Systematic studies comparing the cellular composition and extracellular matrix content of the right and left ventricle have not been performed.
While the left ventricle is derived exclusively from the first heart field, the RV derives in part from the second heart field, which is characterized by increased proliferative activity and differentiation delay. 16 Moreover, the low resistance of the pulmonary vascular territory reduces energy demands on the right ventricular myocardium, leading to thinner walls, a lower muscle mass and increased compliance. 17 To what extent the distinct embryologic origin and the lower pressure load affect the cellular composition and extracellular matrix content of the RV in the absence of injury remains unknown. At birth, right and left ventricles have comparable collagen content; neonatal remodelling of the heart leads to regression in right ventricular myocyte size, resulting in a relative increase of collagen content in the adult right ventricle. 18, 19 In normal adult rats, a hydroxyproline assay demonstrated a lower collagen content in the left ventricular free wall, when compared with the right ventricle and the interventricular septum. 20 On the other hand, experiments comparing fibroblasts from different sites suggested no significant differences in transcriptomic profiles between right ventricular and left ventricular cardiac fibroblasts. 21, 22 All forms of myocardial injury activate the cardiac interstitium leading to expansion of interstitial cell populations and dynamic alterations in the composition of the extracellular matrix.
The right ventricular interstitium in heart disease
The RV tolerates a volume load much better than a pressure load and is more sensitive to changes in afterload than the left ventricle.
23 Figure 1 The right ventricular interstitium. (A) The adult mammalian myocardium is comprised of cardiomyocytes, abundant microvessels (EC, endothelial cells) and a highly cellular interstitium that contains large numbers of fibroblasts (F), pericytes (P) and smaller populations of macrophages (Ma) and other immune cells, enmeshed into a collagen-based matrix. Although systematic comparison of the cellular composition and matrix content between the right and the left ventricular myocardium has not been performed, the interstitium of the RV and the left ventricle have similar morphological characteristics. (B and C) Representative images show staining with picrosirius red of sections from the right ventricular free wall (B, RV) and the left ventricular free wall (C, LV) in adult mouse hearts, in order to identify the collagen network. The epimysial collagen surrounds the organ (arrow); each cardiomyocyte is associated with a thin rim of endomysial collagen (arrowhead). (D, E) Dual fluorescence for wheat germ agglutinin outlines the cardiomyocytes in the mouse right ventricle (D, RV) and in the left ventricular free wall (E, LV). Experimental studies in adult rats have suggested that due to the lower baseline pressure load and the smaller size of right ventricular cardiomyocytes, the RV exhibits a higher relative collagen content, when compared with the left ventricle and the interventricular septum. 20 
(F)
Immunohistochemical staining for the macrophage-specific antibody Mac2 identified a resident macrophage population in the right ventricular wall (arrows). Moreover, due to a more favourable supply and demand ratio, the RV is less susceptible to ischemic injury. Thus, in human patients, the most common pathophysiological cause of right ventricular failure is pressure overload due to pulmonary hypertension. The impact of pressure overload on the RV is dependent not only on the magnitude of the pressure increase but also on the underlying aetiology, and on the rate of progression of the changes in pulmonary pressures. A sudden increase in pulmonary pressures following massive acute pulmonary embolism causes a marked elevation in right ventricular end-diastolic volume, as the chamber attempts to compensate in order to maintain stroke volume. Marked acute increases in pulmonary pressures overwhelm the compensatory response, leading to rapid development of right ventricular failure. In contrast, chronic progressive elevations of pulmonary pressures are better tolerated by the RV and lead to extensive remodelling, involving both the cardiomyocytes and the right ventricular interstitium.
The extracellular matrix in acute right ventricular pressure overload
Descriptive studies in experimental models of acute pulmonary embolism demonstrated rapid infiltration of the right ventricular outflow tract (RVOT) with neutrophils and monocytes, accompanied by local activation of matrix metalloproteinases (MMPs), 24 followed by stimulation of a pro-fibrotic program. 25 Early matrix degradation may contribute to the pathogenesis of acute right ventricular failure, depriving the cardiomyocytes from important pro-survival signals, or abrogating matrixdependent pathways that preserve cardiomyocyte function. In three studies performed by the same group in rat, canine and ovine models of acute pulmonary embolism pre-treatment with doxycycline, a broad non-selective MMP inhibitor attenuated right ventricular dilation [26] [27] [28] and decreased cardiomyocyte injury. 27 Considering the broad effects of doxycycline on inflammatory signalling and oxidative stress, 29 whether the protective actions reflect attenuated matrix degradation remains unknown.
The extracellular matrix in chronic pressure overload
Chronic right ventricular pressure overload increases wall stress and promotes a hypertrophic response. Right ventricular mass is significantly increased in PH patients 30 and right ventricular hypertrophy is consistently observed in experimental models of PH. However, in human patients, the likelihood of progression to right ventricular failure cannot be explained by differences in right ventricular mass or in pressure load. Despite similar elevations in right ventricular pressures and comparable right ventricular hypertrophy, some patients remain stable for decades, while others rapidly decompensate developing right ventricular failure. 8, 31 The aetiology of PH plays a major role in determining the outcome. For example, right ventricular failure is highly prevalent in patients with scleroderma-induced PH. 32 In contrast, patients with right ventricular pressure overload caused through purely mechanical causes (such as pulmonic stenosis) exhibit prolonged concentric hypertrophy without significant contractile depression. 33, 31 Animal models recapitulate this heterogeneity, as development of right ventricular dysfunction is dependent not only on the severity of pressure overload but also on the underlying pathophysiological basis. 34 In models of PH due to administration of endothelial toxins (such as monocrotaline), right ventricular failure is more prominent than in models of mechanical pressure overload induced through pulmonary artery banding. 35 Distinct responses of interstitial cells and the extracellular matrix may explain the heterogeneity of the functional responses of the RV to the various pathophysiological conditions causing PH.
Fibrosis in the pressure-overloaded right ventricular myocardium
A growing body of evidence suggests that right ventricular fibrosis, the expansion of the interstitium through deposition of collagenous matrix, may play an important role in the pathogenesis of right ventricular dysfunction and failure following pressure overload. Magnetic resonance imaging (MRI) suggests that many patients with PH exhibit evidence of right ventricular fibrosis. 36 Histological studies have demonstrated increased collagen deposition in the RV from patients with end-stage PH undergoing heart-lung transplantation. 30 In experimental models of right ventricular pressure overload, fibrotic remodelling of the RV is often associated with decompensation and evidence of severe systolic dysfunction. 37 Ex vivo studies suggested that the contribution of fibrosis to the increased right ventricular stiffness increases with worsening severity of dysfunction. 38 Increased collagen deposition in the RV following pressure overload is due to new synthesis of collagen protein, 39 and is associated with a disproportionate increase in collagen I secretion, 38 a subtype exhibiting higher tensile strength and reduced elasticity when compared with type III collagen. Perturbation of the collagen I:III ratio may be responsible, at least in part, for the increase in right ventricular stiffness following pressure overload.
In the model of pulmonary artery banding, late increases in the levels of insoluble collagen are noted and are associated with right ventricular diastolic dysfunction. 40 Accumulation of insoluble collagen may reflect cross-linking of the right ventricular interstitial matrix; however, the potential involvement of specific cross-linking enzymes, such as lysyloxidases and tissue transglutaminase has not been investigated.
The cellular effectors implicated in right ventricular fibrosis and remodelling
Our current understanding of the cell biological events responsible for fibrotic remodelling of the pressure-overloaded RV is based predominantly on descriptive experiments and on extrapolation of findings from studies investigating left ventricular fibrosis. Thus, the prevailing paradigm ( Figure 2 ) assumes similar cellular properties and mechanism of activation for right and left ventricular myocardial cells, and has not been systematically validated by direct experimentation.
Fibroblasts.
Cardiac fibroblasts are the main effector cells in cardiac fibrosis. 41 Extensive evidence suggests that fibrosis of the pressure-overloaded RV is associated with activation and expansion of fibroblasts, which acquire a myofibroblast phenotype and secrete large amounts of extracellular matrix proteins. In a rabbit model of pulmonary artery constriction, early infiltration of the myocardium with mononuclear cells was noted 2 days after banding and was associated with evidence of cardiomyocyte injury. After 7 days of banding, resolution of the inflammatory infiltrate was accompanied by recruitment of activated myofibroblasts, expressing a-smooth muscle actin. After 14 days, the right ventricular interstitium contained significant amounts of fibrillar collagen. 42 Activated myofibroblasts in the pressure-overloaded RV synthesize large amounts of collagen and secrete matricellular proteins. 40 The time course of these cellular alterations suggests that fibrogenic activation may be dependent on early induction of inflammation in the pressure-overloaded RV, either through direct stimulation of mechanosensitive pro-inflammatory signalling pathways, or secondary to cardiomyocyte necrosis. Direct stimulation of resident cardiac fibroblasts through activation of neurohumoral or growth factor-mediated pathways may also contribute to the fibrotic response. The cellular origin of fibroblasts in the remodelling RV has not been systematically investigated. Recent lineage tracing experiments demonstrated that in experimental models of left ventricular pressure overload, resident cardiac fibroblast populations are the main source of activated myofibroblasts. 43, 44 Endothelial to mesenchymal transdifferentiation and circulating fibroblast progenitors may also contribute smaller, but potentially important, fibroblast subsets. 45 The distinct embryologic, morphologic and functional characteristics of the RV, and the unique features of the right ventricular response to injury may have an impact on the relative contributions of various cell types in right ventricular fibrosis.
Macrophages and lymphocytes.
The adult mouse RV contains a sparse population of macrophages. 15 Right ventricular pressure overload is associated with significant expansion of the macrophage population in the right ventricular wall. 46 Moreover, patients with PH exhibit significantly increased macrophage density in the RV. 47 In models of left ventricular pressure overload, cardiac macrophages have been implicated in the activation of a fibrogenic program. 48 Expansion of the macrophage population in the pressure-overloaded myocardium may be triggered through chemokine-dependent mechanisms. 49 Moreover, neurohumoral mediators may activate macrophages towards a pro-fibrotic phenotype characterized by secretion of growth factors and cytokines. Unfortunately, experimental evidence supporting this plausible concept is lacking, as studies investigating the contribution of macrophages in right ventricular fibrosis have not been performed.
A growing body of evidence implicates lymphocytes in the pathogenesis of myocardial fibrosis in experimental models of left ventricular pressure overload. 50 In a model of transverse aortic constriction, CD4þ T cells-mediated fibrosis, decompensation, and transition to heart failure. 51 Although systemic aldosterone infusion leads to recruitment of lymphocytes in the RV, 52 the potential involvement of lymphocyte subpopulations in right ventricular fibrosis has not been investigated.
Mast cells. Mast cells have been implicated in the pathogenesis
of left ventricular remodelling and fibrosis. 53 Mast cells accumulate in the injured myocardium and degranulate, releasing fibrogenic cytokines and growth factors, and secreting mast cell-specific mediators with fibroblast-activating properties, such as histamine, tryptase, and chymase. [54] [55] [56] In rodent models of pulmonary artery banding, significant increases in mast cell density were observed in the right ventricular myocardium. 57, 58 Whether mast cell-derived mediators critically regulate the fibrotic response in the RV has not been investigated. ; these effects may trigger an angiotensin-driven fibrogenic program following pressure overload. Moreover, stimulated cardiomyocytes may be an important source of transforming growth factor (TGF)-b, 60 a crucial fibrogenic mediator that promotes myofibroblast transdifferentiation and induces extracellular matrix protein synthesis. 61 The potential contribution of pressure-overloaded right ventricular cardiomyocytes in fibrotic remodelling of the RV has not been investigated.
Vascular cells.
In the pressure-overloaded myocardium, vascular endothelial cells may be an important source of fibrogenic mediators, such as endothelin-1. Right ventricular capillary rarefaction is a consistent characteristic of maladaptive right ventricular hypertrophy in both animal models of pressure overload and in human patients with PH. 8, 62, 63 Reduced perfusion of the right ventricular wall may exacerbate local ischemia, thus promoting a fibrogenic response. Although capillary loss in the RV may reflect transdifferentiation of vascular endothelial cells or pericytes to fibroblasts, evidence suggesting an important role for vascular cells as a cellular source for activated fibroblasts infiltrating the pressure overloaded RV is lacking.
Molecular signals mediating right ventricular fibrosis
Development of fibrosis in the pressure-overloaded RV involves activation of mechanosensitive signalling pathways that release neurohumoral mediators, stimulate inflammatory responses, and trigger growth factormediated cascades ( Table 1 and Figure 3 ).
Neurohumoral pathways
Sympathetic stimulation and activation of the renin-angiotensin-aldosterone system (RAAS) are prominent features of PH and are implicated in the pathogenesis of right ventricular dysfunction. 64 In experimental models of PH, the administration of the non-selective b-blocker carvedilol, 65 or the b1 adrenergic receptor (AR) antagonist bisoprolol 66 attenuated right ventricular remodelling and decreased fibrosis of the right ventricular wall without affecting pulmonary pressures. Although 59 , 68 .
In models of PH, significantly increased expression of angiotensin converting enzyme was noted in the RV and was localized in fibrotic areas. 69 Evidence supporting an important role for the RAAS in mediating right ventricular fibrosis following pressure overload is predominantly derived from pharmacologic inhibition experiments. In a rabbit model of pulmonary artery banding and in a model of monocrotaline-induced pulmonary hypertension, angiotensin type 1 (AT1) receptor blockade attenuated right ventricular fibrosis. 70, 71 In contrast, experiments in a rat model of pulmonary artery constriction, combined treatment with an AT1 inhibitor and an aldosterone antagonist had no effects on right ventricular dysfunction, did not significantly affect fibrosis, and did not attenuate capillary rarefaction. 72 Currently, there is no evidence to support the use of RAAS inhibition strategies in patients with right ventricular dysfunction due to PH. 
Endothelin-1
Endothelin-1, a powerful vasoconstrictor with potent fibrogenic properties, is critically implicated in the pathogenesis of PH. 74 Endothelin receptor blockade is a safe and effective therapeutic approach for PH patients. 75 A growing body of evidence suggests that, in addition to its actions on the pulmonary vasculature, endothelin-1 may also mediate right ventricular dysfunction and fibrosis. The expression of endothelin and the endothelin type A receptor are significantly upregulated in the RV in experimental models of right ventricular pressure overload and in patients with PH. 76 In the RV, activation of the endothelin-1 axis may promote fibroblast proliferation and stimulate synthesis of extracellular matrix proteins. 77 Endothelin receptor blockade attenuates right ventricular fibrosis in mechanical, angio-obliterative, and hypoxia-induced models of pulmonary hypertension. [78] [79] [80] Whether these actions contribute to the beneficial effects of endothelin inhibition in patients with PH remains unknown.
Oxidative stress
Generation of reactive oxygen species (ROS) plays an important role in fibroblast activation and in deposition of extracellular matrix proteins in the remodelling myocardium. In vivo studies in a model of pulmonary artery constriction demonstrated that right ventricular pressure overload causes a marked increase in oxidative stress in the right ventricular myocardium, and suggested that, when compared to the left ventricle, the RV may exhibit an accentuated oxidative response to a pressure load. 81 Mechanosensitive activation of Rho kinase may play an important role in ROS generation following right ventricular pressure overload. 81 It has been suggested that the exaggerated oxidative response of the RV following stress may be due to defective antioxidant defenses. In a model of NO deficiency induced by L-NAME feeding, the RV exhibited early cardiomyopathic changes, and dilation; in contrast, the left ventricle had only subtle hypertrophic alterations. The selective involvement of the RV in this model was associated with increased oxidative stress and failure to activate antioxidant responses. 82 Treatment with antioxidants attenuated adverse remodelling and dysfunction of the RV, reducing right ventricular fibrosis in the rat monocrotaline model of pulmonary hypertension. 
Inflammatory signals
Pro-inflammatory cytokines and chemokines play an important role in fibrotic remodelling in many tissues, including the myocardium, both through direct stimulation of fibroblasts and through induction of fibrogenic signals in other cell types (such as macrophages and vascular cells). 84 Our understanding of the role of inflammatory mediators in right ventricular fibrosis is based on descriptive evidence and on known effects of these signals in left ventricular disease. In a mouse model of pulmonary artery constriction, marked upregulation of several members of the chemokine family was noted in the pressure-overloaded RV, including the CC chemokines CCL2 and CCL5, the CXC chemokines CXCL16 and CXCL10, and CX3CL1. 85 Neurohumoral mediators, generation of ROS, and direct activation of mechanosensitive proinflammatory signals in cardiomyocytes and macrophages may explain the induction of inflammatory genes in the pressure-overloaded RV. In vitro studies suggested that CXCL16, CX3CL1, and CCL5 may increase expression of the small leucine-rich glycoproteins decorin, biglycan, lumican, and fibromodulin, important activators of the fibrotic response. 85 CCL2 may also be implicated in the fibrotic myocardial response by recruiting mononuclear cells that may activate cardiac fibroblasts. 86 On the other hand, induction of the anti-fibrotic chemokine CXCL10 87,88 may serve as an endogenous inhibitory signal that restrains the fibrotic response.
The TGF-b superfamily
Several members of the TGF-b superfamily have been implicated in regulation of tissue fibrosis and extracellular matrix remodelling. TGF-b1 is critically involved in activation of a pro-fibrotic program, by inducing synthesis of extracellular matrix proteins and by promoting myofibroblast transdifferentiation. 61 On the other hand, members of the bone morphogenetic protein (BMP) subfamily, such as BMP-2 and BMP-7, may attenuate fibrosis by inhibiting TGF-b actions. 45 ,89,90
. The role of TGF-b signalling pathways in mediating right ventricular dysfunction and fibrosis 
following pressure overload is poorly understood. TGF-b1 upregulation has been demonstrated in the RV in models of pulmonary artery constriction and in pulmonary hypertension secondary to left sided heart failure 91 ; however, findings on downstream activation of TGF-b signalling cascades are conflicting. In an experimental model of pulmonary artery banding, increased levels of phosphorylated Smad2 (p-Smad2) in the right ventricular myocardium suggested activation of TGF-b signalling. 70 However, in patients with end-stage pulmonary hypertension, p-Smad2 immunoreactivity in the RV was reduced, when compared with controls. 92 The contradictory findings may reflect the dynamic regulation of the TGF-b cascade in vivo. Early activation of the pathway in the pressure-overloaded myocardium may be followed by induction of inhibitory signals that restrain TGF-b/Smad signalling. Dissection of the in vivo actions of TGF-b family members is hampered by the wide range of their context-dependent effects that target many different cell types. In models of reparative and interstitial left ventricular fibrosis, both Smad-dependent and Smad-independent actions of TGF-b signalling have been suggested to play important roles in regulation of fibroblast responses [93] [94] [95] [96] and in deposition of extracellular matrix proteins. Experiments investigating the in vivo role of TGF-b signalling cascades in fibrosis and remodelling of the RV have not been performed. Experimental studies in both angio-obliterative and surgical models of right ventricular pressure overload suggested that endoglin, an accessory receptor for the TGF-b family, may mediate fibrosis and dysfunction of the RV. 
The matricellular proteins
Matricellular proteins are extracellular macromolecules that do not serve a primary structural role, but are secreted following injury and modulate growth factor and cytokine responses. In the remodelling myocardium, the extracellular matrix is enriched through the deposition of matricellular proteins. Over the last 10-15 years, experimental studies have suggested that several members of the matricellular family (including the thrombospondins, tenascins, osteopontin, SPARC, periostin, and members of the CCN family) are markedly induced in the injured and pressure overloaded left ventricle and play a critical role in regulating inflammatory, fibrotic, and angiogenic responses. 11, [98] [99] [100] [101] The potential involvement of members of the matricellular proteins in remodelling of the pressure-overloaded RV is suggested almost exclusively by descriptive studies. Right ventricular upregulation of osteopontin, tenascin-C, SPARC, and CCN2 has been documented in experimental models of PH. 40, 70, 102, 103 Induction of matricellular proteins in the pressureoverloaded RV may be mediated through the activation of neurohumoral and inflammatory pathways and may involve activation of TGF-b.
Investigations examining the role of matricellular actions in regulating right ventricular fibrosis, matrix remodelling, and dysfunction have not been performed.
The extracellular matrix in right ventricular volume overload
Pure right ventricular volume overload is generally well tolerated by human patients and experimental animals. Many patients with tetralogy of Fallot develop pulmonary insufficiency that typically has minimal consequences over several decades, but can be the source of late complications including right ventricular dysfunction due to chronic volume overload. 104 In both large animal and rodent models of pulmonary insufficiency, right ventricular volume overload resulted in dilation of the RV, accompanied by diastolic dysfunction, without affecting systolic function. 105, 106 In the mouse model, right ventricular volume overload was associated with development of subendocardial fibrosis in the right ventricular wall. Dynamic changes in the expression of matrix remodelling genes were observed: early downregulation of some members of the TGF-b superfamily (such as growth differentiation factor (GDF)-5 and GDF-7) was followed by late induction of cytokines and chemokines, TGF-b1 upregulation and increased transcription of matricellular proteins (including thromsbospondin-1 and periostin). 105 The functional significance of these alterations remains unknown.
Right ventricular infarction
Although the cellular events and molecular pathways involved in fibrotic repair of the infracted left ventricle have been extensively characterized, 107 much less is known about the response of the RV to infractive injury. In the clinic, right ventricular infarction is quite common; 40-50% of patients with acute inferior myocardial infarction exhibit right ventricular involvement. 108 Experimental animal models and clinical experience suggest that although early functional depression of the RV following infarction may have adverse consequences, the right ventricular myocardium is resistant to infarction and recovers even after prolonged coronary occlusion. 109 In human patients with early right ventricular ischemic dysfunction, the function of the RV returns to normal within 3-12 months. 110 In the dog, persistent occlusion of the right coronary artery does not cause infarction. 111 The more favourable balance between oxygen supply and demand explains the reduced vulnerability of the RV to ischemic injury. The extensive collateralization of the RV provides more reliable blood supply under ischemic conditions, while the lower myocardial mass and the reduced afterload account for the decreased demand, in comparison to the left ventricular myocardium. Moreover, the RV exhibits higher capabilities to extract oxygen under conditions of stress, due to its low oxygen contraction levels at rest. Whether differences in the matrix composition of the cardiac interstitium, or distinct functional properties of right ventricular fibroblasts and immune cells contribute to the unique response of the RV to ischemia is unknown.
The right ventricular extracellular matrix in arrhythmogenic cardiomyopathies
Myocardial fibrosis perturbs propagation of the electrical impulse and has been implicated in arrhythmia generation. Evidence of right ventricular interstitial or perivascular fibrosis was found in 56% of patients with ventricular arrhythmias in the absence of clinical structural heart disease. 112 Interstitial fibrosis in the RVOT has been detected in patients with sudden cardiac death related to Brugada syndrome. 113 In patients with hypertrophic cardiomyopathy, right ventricular fibrosis predicted arrhythmic events. 114 Individuals with arrhythmogenic right ventricular cardiomyopathy (ARVC) exhibit expansion of right ventricular fibroadipocytes, leading to fibrosis and fatty infiltration. [115] [116] [117] [118] The mechanisms responsible for the marked alterations in myocardial cellular composition in patients with ARVC and other arrhythmogenic cardiomyopathies remain unknown. Genetic studies have identified mutations in genes encoding desmosome proteins as the underlying cause in many patients with ARVC. Mutations in PKP2, which encodes plakophilin-2, in desmoplakin, and desmoglein-2 have been identified in many patients with ARVC. [119] [120] [121] In mice, loss of desmoplakin in a subset of interstitial cells with fibroadipocyte characteristics promotes adipocyte differentiation through a Wnt-dependent mechanism. 122, 123 The cellular link between these mutations and right ventricular fibrosis is less
Interstitial remodelling of the right ventricle clear. Fibrosis may reflect cardiomyocyte injury, or primary activation of interstitial cell populations and transition to a fibroblast phenotype. 124 Recent cell biological experiments suggested that plakophilin-2 loss promotes TGF-b1 expression and may activate a fibrogenic program in cardiomyocytes. 125 The significance of these actions in the pathogenesis of fibrosis in ARVC remains unclear.
Right ventricular fibrosis in response to cancer chemotherapy
Patients treated with anthracyclines as cancer chemotherapy exhibit a high incidence of cardiac complications. Acute anthracycline cardiotoxicity is rare in human patients and is associated with dose-dependent cardiomyocyte injury and secondary inflammation. 126 Chronic cardiotoxicity on the other hand, may occur within 1 year after completion of treatment (early-onset chronic cardiomyopathy), or may affect cancer survivors many years after therapy (late-onset chronic cardiomyopathy). 127 A growing body of evidence suggests that interstitial fibrosis may be an important component of the cardiac pathology in cancer survivors exposed to anthracyclines. Magnetic resonance imaging showed enhanced chronic fibrotic changes in anthracycline-treated patients. 128 Moreover, late development of systolic heart failure, arrhythmias, and sudden death in patients treated with anthracyclines was associated with histological evidence of myocardial fibrosis. 129, 130 In animal models of doxorubicin toxicity, a subacute increase in myocardial fibrosis was strongly linked with late mortality. 131 Data on the extent of right ventricular fibrotic remodelling following anthracycline administration are conflicting. In a mouse model, doxorubicin administration significantly increased collagen deposition in both the left and the right ventricle. 132 In contrast, in rabbits treated with daunorubicin fibrotic, changes were reported to be much less severe in the right ventricle. 133 Species-specific effects, differences in the dose of the anthracycline, and in the timing of assessment of fibrosis may explain the conflicting findings. The cellular basis of fibrosis in response to anthracycline treatment has not been systematically studied. Fibrotic changes may represent an epiphenomenon, reflecting activation of a reparative program in response to anthracycline-induced cardiomyocyte death. Direct effects of anthracyclines on fibroblasts should also be considered. A recent study suggested that doxorubicin-induced generation of reactive oxygen species may activate ataxia telangiectasia mutated (ATM) kinase in cardiac fibroblasts promoting a fibrotic response. 134 
The profibrotic effects of cigarette smoke
A recently published study suggested that cigarette smoke exposure may increase right ventricular collagen content in mice, suppressing right ventricular function, in the absence of any effects on the left ventricle and on the pulmonary vasculature. 135 The profibrotic effects of cigarette smoke were attributed to nicotine-mediated activation of a7 nicotine acetylcholine receptor signalling in cardiac fibroblasts. The basis for the selective involvement of the RV is unknown. Direct profibrotic effects of cigarette smoke may explain the presence of right ventricular dysfunction in some patients with chronic obstructive pulmonary disease, despite the absence of pulmonary hypertension. 
Right ventricular fibrosis in response to left ventricular disease
Although the systemic and the pulmonary circulation are arranged in series, there are several layers of functional integration between the left and the right ventricle. The common pericardium that encircles both chambers, the continuity between the muscle fibres of the left and right ventricular-free wall, the shared interventricular septum, and perfusion by the coronary arterial system generate a physiologic interdependence between the right and the left ventricle. In left ventricular disease, additional mechanisms contribute to structural remodelling and dysfunction of the RV. In an experimental model of left ventricular myocardial infarction, a marked upregulation in right ventricular collagen type I and III mRNA synthesis was reported, peaking 7-14 days after coronary occlusion. Collagen deposition was followed by significantly increased right ventricular stiffness, 56 days after infarction. 137 Moreover, increased right ventricular stiffness is noted in a model of left ventricular pressure overload, 138 and in a model of renovascular hypertension, interstitial fibrosis is noted in both the pressure-overloaded left ventricle and in the RV. 19 Structural remodelling of the extracellular matrix network of the RV in response to left ventricular disease is, at least in part, secondary to the increased right ventricular pressures caused by left ventricular failure, but may also reflect systemic activation of neurohumoral pathways that affect both ventricles. 3. 9 . The right ventricular interstitium in senescent and diabetic hearts
Aging, obesity, and diabetes are associated with interstitial and perivascular cardiac fibrosis that may contribute to diastolic dysfunction. [139] [140] [141] Some studies have reported that in senescent mice, the fibrotic response may be more diffuse in the RV than in the left ventricle, suggesting that these changes may explain the aging-associated increase in the incidence of arrhythmias. 142, 143 Moreover, in a rat model of type 1 diabetes, significant RV fibrosis was noted in the absence of hypertrophy or cardiomyocyte apoptosis. 144 Whether these observations are relevant in senescent or diabetic human subjects remains unknown.
Does the right ventricular interstitium exhibit unique pathophysiological responses?
Although the importance of right ventricular dysfunction in patients with cardiac and pulmonary disease is widely appreciated, understanding of the pathophysiological underpinnings of right ventricular failure remains limited. This is due, at least in part, to the notion that considering the intense research interest on the cell biological responses to left ventricular injury, relatively little additional information can be derived by investigating interactions between the same cell types in the RV. In the absence of injury, right and left ventricular fibroblasts appear to have similar characteristics; the matrix networks of the left and the right ventricle share common structural properties. However, the right ventricular predilection of certain genetic conditions associated with interstitial remodelling, such as ARVC, suggests unique characteristics of the interstitial cells populating the right ventricular wall. The cellular composition of the RV has not been systematically studied and the molecular links between genetic alterations and right ventricular interstitial remodelling remain unknown. Moreover, various diseases impose unique pathophysiological challenges to the right ventricular interstitium. In conditions associated with right ventricular pressure overload, the dramatic pressure increases would be expected to transduce potent activating signals in interstitial cells populating the RV. Under hypoxic conditions, the favourable
oxygen supply and demand relations in the RV may result in distinct interstitial cell responses. To what extent the relative resistance of the RV to infarctive injury is dependent on unique properties of the right ventricular interstitium remains unknown. Thus, understanding the pathobiology of right ventricular interstitial cells may provide unique insights into strategies to improve adverse remodelling in left ventricular diseases.
Conclusions
A growing body of evidence suggests that phenotypic and functional alterations of interstitial cell populations and changes in the composition of the extracellular matrix network may play an important role in the pathogenesis of right ventricular dysfunction in a wide range of pathologic conditions. Our current understanding of the cell biological mechanisms and molecular signals involved in right ventricular fibrosis is based to a large extent on extrapolation from studies investigating left ventricular remodelling. Although the two ventricles have similarities in cellular composition and share several layers of functional integration, they also exhibit significant differences in embryologic origin, physiologic properties, and pathophysiological responses. Studies dissecting RV-specific cellular responses to injury are needed in order to understand the basis for right ventricular remodelling and dysfunction. Insights into the mechanisms of right ventricular fibrosis are necessary in order to develop novel therapeutic strategies to prevent right ventricular dysfunction in patients with pulmonary hypertension, and to inhibit arrhythmia generation in patients with right ventricular cardiomyopathies.
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